Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 264

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

Open access
Sorror, Mohamed, Storer, Barry, Sandmaier, Brenda M., Maloney, David G., Chauncey, Thomas R., Langston, Amelia, Maziarz, Richard T., Pulsipher, Michael, McSweeney, Peter A., Storb, Rainer·2008·Cancer

Abstract

BACKGROUND: Elderly and medically infirm cancer patients are increasingly offered allogeneic nonmyeloablative hematopoietic cell transplantation (HCT). A better understanding of the impact of health status on HCT outcomes is warranted. Herein, a recently developed HCT‐specific comorbidity index (HCT‐CI) was compared with a widely acceptable measure of health status, the Karnofsky performance status (KPS). METHODS: The outcomes of 341 patients were evaluated, conditioned for either related or unrelated HCT by 2‐gray (Gy) total body irradiation given alone or combined with fludarabine at a dose of 90 mg/m 2. Comorbidities were assessed retrospectively by the HCT‐CI. Performance status before and toxicities after HCT were graded prospectively using the KPS and National Cancer Institute Common Toxicity criteria, respectively. RESULTS: Weak Spearman rank correlations were noted between HCT‐CI and KPS and between the 2 measures and age, number of prior chemotherapy regimens, and intervals between diagnosis and HCT (all r < 0.20). High‐risk diseases correlated significantly with higher mean HCT‐CI scores (P = .009) but not low KPS (P = .37). In multivariate models, the HCT‐CI had significantly greater independent predictive power for toxicities (P = .004), nonrelapse mortality (P = .0002), and overall mortality (P = .0002) compared with the KPS (P = .05, .13, and .05, respectively). Using consolidated HCT‐CI and KPS scores, patients were stratified into 4 risk groups with 2‐year survivals of 68%, 58%, 41%, and 32%, respectively. CONCLUSIONS: HCT‐CI and KPS should be assessed simultaneously before HCT. The use of both tools combined likely refines risk‐stratification for HCT outcomes. Novel guidelines for assessment of performance status among HCT patients are warranted. Cancer 2008. © 2008 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.23375

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 264

Metadata

Authors
Sorror, M., Storer, B., Sandmaier, B. M., Maloney, D. G., Chauncey, T. R., Langston, A., Maziarz, R. T., Pulsipher, M., McSweeney, P. A., & Storb, R.
Venue
Cancer
Publisher
Wiley
Published
2008-04-21
Volume
112
Issue
9
Pages
1992-2001
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1999533140
Cited by
264
References
2
FWCI
12.02
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation. https://app.cochat.ai/papers/10.1002/cncr.23375
The paper
Sorror, M., Storer, B., Sandmaier, B. M., Maloney, D. G., Chauncey, T. R., Langston, A., Maziarz, R. T., Pulsipher, M., McSweeney, P. A., & Storb, R. (2008). Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation. Cancer. https://doi.org/10.1002/cncr.23375

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.